General contact

Main switchboard

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 a.m. - 5:00 p.m. GMT+1

US switchboard

+1 862 778 21 00
Monday - Friday,
8:30 a.m. - 5:00 p.m. EST


Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999


Investor Relations

Monday - Friday,
8:30 a.m. - 5:30 p.m. GMT+1
(Central European Time)

Reporting side effects

Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.

Reporting side effects

pane 4 content

Responsibly tackling the challenging issues

Novartis is committed to tackling the many global health challenges through innovative approaches to research and development. We recognize that our efforts to push the boundaries of knowledge in the field of human health may give rise to ethical issues.

We are committed to upholding high standards of ethics across our business and to transparently setting out our position on these challenging issues. Novartis recognizes the importance of informed stakeholder debate on such issues and welcomes the opportunity to engage in constructive dialogue.